 | • レポートコード：QY2108PAL4027 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はプラミペキソールの世界市場の現状について調査・分析し、2027年までの市場を予測しました。プラミペキソールの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（錠剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン販売、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・プラミペキソールの世界市場概要 ・メーカー別の競争状況、市場シェア ・プラミペキソールの種類別市場規模：錠剤、その他 ・プラミペキソールの用途別市場規模：病院薬局、小売薬局、オンライン販売、その他 ・北米のプラミペキソール市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのプラミペキソール市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのプラミペキソール市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のプラミペキソール市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのプラミペキソール市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Deva Holdings、Boehringer Ingelheim、WELLONA PHARMA、Torrent Group、Sun Pharma、Zhejiang Jingxin Pharmaceutical Co., Ltd、CSPC、Haisco Pharmaceutical Group、LP Pharmaceutical (Xiamen) Co., Ltd. ・プラミペキソールのバリューチェーン・販売チャネル分析 ・プラミペキソールの世界市場動向 |
Pramipexole is a dopamine agonist that works on the nervous system to help treat the symptoms of Parkinson disease. Pramipexole is also used to treat Restless Legs Syndrome (RLS). RLS is a neurologic disorder that affects sensation and movement in the legs and causes the legs to feel uncomfortable.
Market Analysis and Insights: Global Pramipexole Market
The global Pramipexole market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Pramipexole Scope and Segment
Pramipexole market is segmented by Type, and by Sales Channel. Players, stakeholders, and other participants in the global Pramipexole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2016-2027.
Segment by Type
Tablets
Others
Segment by Sales Channel
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others
By Company
Deva Holdings
Boehringer Ingelheim
WELLONA PHARMA
Torrent Group
Sun Pharma
Zhejiang Jingxin Pharmaceutical Co., Ltd
CSPC
Haisco Pharmaceutical Group
LP Pharmaceutical (Xiamen) Co., Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Pramipexole Product Introduction
1.2 Market by Type
1.2.1 Global Pramipexole Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Others
1.3 Market by Sales Channel
1.3.1 Global Pramipexole Market Size Growth Rate by Sales Channel
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pramipexole Sales Estimates and Forecasts 2016-2027
2.2 Global Pramipexole Revenue Estimates and Forecasts 2016-2027
2.3 Global Pramipexole Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Pramipexole Regions by Sales
2.4.1 Global Top Pramipexole Regions by Sales (2016-2021)
2.4.2 Global Top Pramipexole Regions by Sales (2022-2027)
2.5 Global Top Pramipexole Regions by Revenue
2.5.1 Global Top Pramipexole Regions by Revenue (2016-2021)
2.5.2 Global Top Pramipexole Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pramipexole Sales by Manufacturers
3.1.1 Global Top Pramipexole Manufacturers by Sales (2016-2021)
3.1.2 Global Top Pramipexole Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Pramipexole Sales in 2020
3.2 Global Pramipexole Revenue by Manufacturers
3.2.1 Global Top Pramipexole Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Pramipexole Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Pramipexole Revenue in 2020
3.3 Global Pramipexole Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pramipexole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pramipexole Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pramipexole Sales by Type
4.1.1 Global Pramipexole Historical Sales by Type (2016-2021)
4.1.2 Global Pramipexole Forecasted Sales by Type (2022-2027)
4.1.3 Global Pramipexole Sales Market Share by Type (2016-2027)
4.2 Global Pramipexole Revenue by Type
4.2.1 Global Pramipexole Historical Revenue by Type (2016-2021)
4.2.2 Global Pramipexole Forecasted Revenue by Type (2022-2027)
4.2.3 Global Pramipexole Revenue Market Share by Type (2016-2027)
4.3 Global Pramipexole Price by Type
4.3.1 Global Pramipexole Price by Type (2016-2021)
4.3.2 Global Pramipexole Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Pramipexole Sales by Sales Channel
5.1.1 Global Pramipexole Historical Sales by Sales Channel (2016-2021)
5.1.2 Global Pramipexole Forecasted Sales by Sales Channel (2022-2027)
5.1.3 Global Pramipexole Sales Market Share by Sales Channel (2016-2027)
5.2 Global Pramipexole Revenue by Sales Channel
5.2.1 Global Pramipexole Historical Revenue by Sales Channel (2016-2021)
5.2.2 Global Pramipexole Forecasted Revenue by Sales Channel (2022-2027)
5.2.3 Global Pramipexole Revenue Market Share by Sales Channel (2016-2027)
5.3 Global Pramipexole Price by Sales Channel
5.3.1 Global Pramipexole Price by Sales Channel (2016-2021)
5.3.2 Global Pramipexole Price Forecast by Sales Channel (2022-2027)
6 North America
6.1 North America Pramipexole Market Size by Type
6.1.1 North America Pramipexole Sales by Type (2016-2027)
6.1.2 North America Pramipexole Revenue by Type (2016-2027)
6.2 North America Pramipexole Market Size by Sales Channel
6.2.1 North America Pramipexole Sales by Sales Channel (2016-2027)
6.2.2 North America Pramipexole Revenue by Sales Channel (2016-2027)
6.3 North America Pramipexole Market Size by Country
6.3.1 North America Pramipexole Sales by Country (2016-2027)
6.3.2 North America Pramipexole Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pramipexole Market Size by Type
7.1.1 Europe Pramipexole Sales by Type (2016-2027)
7.1.2 Europe Pramipexole Revenue by Type (2016-2027)
7.2 Europe Pramipexole Market Size by Sales Channel
7.2.1 Europe Pramipexole Sales by Sales Channel (2016-2027)
7.2.2 Europe Pramipexole Revenue by Sales Channel (2016-2027)
7.3 Europe Pramipexole Market Size by Country
7.3.1 Europe Pramipexole Sales by Country (2016-2027)
7.3.2 Europe Pramipexole Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pramipexole Market Size by Type
8.1.1 Asia Pacific Pramipexole Sales by Type (2016-2027)
8.1.2 Asia Pacific Pramipexole Revenue by Type (2016-2027)
8.2 Asia Pacific Pramipexole Market Size by Sales Channel
8.2.1 Asia Pacific Pramipexole Sales by Sales Channel (2016-2027)
8.2.2 Asia Pacific Pramipexole Revenue by Sales Channel (2016-2027)
8.3 Asia Pacific Pramipexole Market Size by Region
8.3.1 Asia Pacific Pramipexole Sales by Region (2016-2027)
8.3.2 Asia Pacific Pramipexole Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pramipexole Market Size by Type
9.1.1 Latin America Pramipexole Sales by Type (2016-2027)
9.1.2 Latin America Pramipexole Revenue by Type (2016-2027)
9.2 Latin America Pramipexole Market Size by Sales Channel
9.2.1 Latin America Pramipexole Sales by Sales Channel (2016-2027)
9.2.2 Latin America Pramipexole Revenue by Sales Channel (2016-2027)
9.3 Latin America Pramipexole Market Size by Country
9.3.1 Latin America Pramipexole Sales by Country (2016-2027)
9.3.2 Latin America Pramipexole Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Pramipexole Market Size by Type
10.1.1 Middle East and Africa Pramipexole Sales by Type (2016-2027)
10.1.2 Middle East and Africa Pramipexole Revenue by Type (2016-2027)
10.2 Middle East and Africa Pramipexole Market Size by Sales Channel
10.2.1 Middle East and Africa Pramipexole Sales by Sales Channel (2016-2027)
10.2.2 Middle East and Africa Pramipexole Revenue by Sales Channel (2016-2027)
10.3 Middle East and Africa Pramipexole Market Size by Country
10.3.1 Middle East and Africa Pramipexole Sales by Country (2016-2027)
10.3.2 Middle East and Africa Pramipexole Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Deva Holdings
11.1.1 Deva Holdings Corporation Information
11.1.2 Deva Holdings Overview
11.1.3 Deva Holdings Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Deva Holdings Pramipexole Product Description
11.1.5 Deva Holdings Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Boehringer Ingelheim Pramipexole Product Description
11.2.5 Boehringer Ingelheim Recent Developments
11.3 WELLONA PHARMA
11.3.1 WELLONA PHARMA Corporation Information
11.3.2 WELLONA PHARMA Overview
11.3.3 WELLONA PHARMA Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 WELLONA PHARMA Pramipexole Product Description
11.3.5 WELLONA PHARMA Recent Developments
11.4 Torrent Group
11.4.1 Torrent Group Corporation Information
11.4.2 Torrent Group Overview
11.4.3 Torrent Group Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Torrent Group Pramipexole Product Description
11.4.5 Torrent Group Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Corporation Information
11.5.2 Sun Pharma Overview
11.5.3 Sun Pharma Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Sun Pharma Pramipexole Product Description
11.5.5 Sun Pharma Recent Developments
11.6 Zhejiang Jingxin Pharmaceutical Co., Ltd
11.6.1 Zhejiang Jingxin Pharmaceutical Co., Ltd Corporation Information
11.6.2 Zhejiang Jingxin Pharmaceutical Co., Ltd Overview
11.6.3 Zhejiang Jingxin Pharmaceutical Co., Ltd Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Zhejiang Jingxin Pharmaceutical Co., Ltd Pramipexole Product Description
11.6.5 Zhejiang Jingxin Pharmaceutical Co., Ltd Recent Developments
11.7 CSPC
11.7.1 CSPC Corporation Information
11.7.2 CSPC Overview
11.7.3 CSPC Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 CSPC Pramipexole Product Description
11.7.5 CSPC Recent Developments
11.8 Haisco Pharmaceutical Group
11.8.1 Haisco Pharmaceutical Group Corporation Information
11.8.2 Haisco Pharmaceutical Group Overview
11.8.3 Haisco Pharmaceutical Group Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Haisco Pharmaceutical Group Pramipexole Product Description
11.8.5 Haisco Pharmaceutical Group Recent Developments
11.9 LP Pharmaceutical (Xiamen) Co., Ltd.
11.9.1 LP Pharmaceutical (Xiamen) Co., Ltd. Corporation Information
11.9.2 LP Pharmaceutical (Xiamen) Co., Ltd. Overview
11.9.3 LP Pharmaceutical (Xiamen) Co., Ltd. Pramipexole Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 LP Pharmaceutical (Xiamen) Co., Ltd. Pramipexole Product Description
11.9.5 LP Pharmaceutical (Xiamen) Co., Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pramipexole Value Chain Analysis
12.2 Pramipexole Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pramipexole Production Mode & Process
12.4 Pramipexole Sales and Marketing
12.4.1 Pramipexole Sales Channels
12.4.2 Pramipexole Distributors
12.5 Pramipexole Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pramipexole Industry Trends
13.2 Pramipexole Market Drivers
13.3 Pramipexole Market Challenges
13.4 Pramipexole Market Restraints
14 Key Findings in The Global Pramipexole Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Pramipexole Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Others
Table 4. Global Pramipexole Market Size Growth Rate by Sales Channel, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Pramipexole Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Pramipexole Sales by Region (2016-2021) & (K Units)
Table 7. Global Pramipexole Sales Market Share by Region (2016-2021)
Table 8. Global Pramipexole Sales by Region (2022-2027) & (K Units)
Table 9. Global Pramipexole Sales Market Share by Region (2022-2027)
Table 10. Global Pramipexole Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Pramipexole Revenue Market Share by Region (2016-2021)
Table 12. Global Pramipexole Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Pramipexole Revenue Market Share by Region (2022-2027)
Table 14. Global Pramipexole Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Pramipexole Sales Share by Manufacturers (2016-2021)
Table 16. Global Pramipexole Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Pramipexole Revenue Share by Manufacturers (2016-2021)
Table 18. Pramipexole Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Pramipexole Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Pramipexole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pramipexole as of 2020)
Table 21. Pramipexole Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pramipexole Product Offered
Table 23. Date of Manufacturers Enter into Pramipexole Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pramipexole Sales by Type (2016-2021) & (K Units)
Table 26. Global Pramipexole Sales by Type (2022-2027) & (K Units)
Table 27. Global Pramipexole Sales Share by Type (2016-2021)
Table 28. Global Pramipexole Sales Share by Type (2022-2027)
Table 29. Global Pramipexole Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Pramipexole Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Pramipexole Revenue Share by Type (2016-2021)
Table 32. Global Pramipexole Revenue Share by Type (2022-2027)
Table 33. Pramipexole Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Pramipexole Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Pramipexole Sales by Sales Channel (2016-2021) & (K Units)
Table 36. Global Pramipexole Sales by Sales Channel (2022-2027) & (K Units)
Table 37. Global Pramipexole Sales Share by Sales Channel (2016-2021)
Table 38. Global Pramipexole Sales Share by Sales Channel (2022-2027)
Table 39. Global Pramipexole Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 40. Global Pramipexole Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 41. Global Pramipexole Revenue Share by Sales Channel (2016-2021)
Table 42. Global Pramipexole Revenue Share by Sales Channel (2022-2027)
Table 43. Pramipexole Price by Sales Channel (2016-2021) & (US$/Unit)
Table 44. Global Pramipexole Price Forecast by Sales Channel (2022-2027) & (US$/Unit)
Table 45. North America Pramipexole Sales by Type (2016-2021) & (K Units)
Table 46. North America Pramipexole Sales by Type (2022-2027) & (K Units)
Table 47. North America Pramipexole Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Pramipexole Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Pramipexole Sales by Sales Channel (2016-2021) & (K Units)
Table 50. North America Pramipexole Sales by Sales Channel (2022-2027) & (K Units)
Table 51. North America Pramipexole Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 52. North America Pramipexole Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 53. North America Pramipexole Sales by Country (2016-2021) & (K Units)
Table 54. North America Pramipexole Sales by Country (2022-2027) & (K Units)
Table 55. North America Pramipexole Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Pramipexole Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Pramipexole Sales by Type (2016-2021) & (K Units)
Table 58. Europe Pramipexole Sales by Type (2022-2027) & (K Units)
Table 59. Europe Pramipexole Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Pramipexole Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Pramipexole Sales by Sales Channel (2016-2021) & (K Units)
Table 62. Europe Pramipexole Sales by Sales Channel (2022-2027) & (K Units)
Table 63. Europe Pramipexole Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 64. Europe Pramipexole Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 65. Europe Pramipexole Sales by Country (2016-2021) & (K Units)
Table 66. Europe Pramipexole Sales by Country (2022-2027) & (K Units)
Table 67. Europe Pramipexole Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Pramipexole Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Pramipexole Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Pramipexole Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Pramipexole Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Pramipexole Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Pramipexole Sales by Sales Channel (2016-2021) & (K Units)
Table 74. Asia Pacific Pramipexole Sales by Sales Channel (2022-2027) & (K Units)
Table 75. Asia Pacific Pramipexole Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 76. Asia Pacific Pramipexole Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 77. Asia Pacific Pramipexole Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Pramipexole Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Pramipexole Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Pramipexole Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Pramipexole Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Pramipexole Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Pramipexole Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Pramipexole Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Pramipexole Sales by Sales Channel (2016-2021) & (K Units)
Table 86. Latin America Pramipexole Sales by Sales Channel (2022-2027) & (K Units)
Table 87. Latin America Pramipexole Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 88. Latin America Pramipexole Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 89. Latin America Pramipexole Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Pramipexole Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Pramipexole Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Pramipexole Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Pramipexole Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Pramipexole Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Pramipexole Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Pramipexole Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Pramipexole Sales by Sales Channel (2016-2021) & (K Units)
Table 98. Middle East and Africa Pramipexole Sales by Sales Channel (2022-2027) & (K Units)
Table 99. Middle East and Africa Pramipexole Revenue by Sales Channel (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Pramipexole Revenue by Sales Channel (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Pramipexole Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Pramipexole Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Pramipexole Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Pramipexole Revenue by Country (2022-2027) & (US$ Million)
Table 105. Deva Holdings Corporation Information
Table 106. Deva Holdings Description and Major Businesses
Table 107. Deva Holdings Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Deva Holdings Pramipexole Product
Table 109. Deva Holdings Recent Developments
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Major Businesses
Table 112. Boehringer Ingelheim Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Boehringer Ingelheim Pramipexole Product
Table 114. Boehringer Ingelheim Recent Developments
Table 115. WELLONA PHARMA Corporation Information
Table 116. WELLONA PHARMA Description and Major Businesses
Table 117. WELLONA PHARMA Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. WELLONA PHARMA Pramipexole Product
Table 119. WELLONA PHARMA Recent Developments
Table 120. Torrent Group Corporation Information
Table 121. Torrent Group Description and Major Businesses
Table 122. Torrent Group Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Torrent Group Pramipexole Product
Table 124. Torrent Group Recent Developments
Table 125. Sun Pharma Corporation Information
Table 126. Sun Pharma Description and Major Businesses
Table 127. Sun Pharma Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Sun Pharma Pramipexole Product
Table 129. Sun Pharma Recent Developments
Table 130. Zhejiang Jingxin Pharmaceutical Co., Ltd Corporation Information
Table 131. Zhejiang Jingxin Pharmaceutical Co., Ltd Description and Major Businesses
Table 132. Zhejiang Jingxin Pharmaceutical Co., Ltd Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Zhejiang Jingxin Pharmaceutical Co., Ltd Pramipexole Product
Table 134. Zhejiang Jingxin Pharmaceutical Co., Ltd Recent Developments
Table 135. CSPC Corporation Information
Table 136. CSPC Description and Major Businesses
Table 137. CSPC Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. CSPC Pramipexole Product
Table 139. CSPC Recent Developments
Table 140. Haisco Pharmaceutical Group Corporation Information
Table 141. Haisco Pharmaceutical Group Description and Major Businesses
Table 142. Haisco Pharmaceutical Group Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Haisco Pharmaceutical Group Pramipexole Product
Table 144. Haisco Pharmaceutical Group Recent Developments
Table 145. LP Pharmaceutical (Xiamen) Co., Ltd. Corporation Information
Table 146. LP Pharmaceutical (Xiamen) Co., Ltd. Description and Major Businesses
Table 147. LP Pharmaceutical (Xiamen) Co., Ltd. Pramipexole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. LP Pharmaceutical (Xiamen) Co., Ltd. Pramipexole Product
Table 149. LP Pharmaceutical (Xiamen) Co., Ltd. Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Pramipexole Distributors List
Table 153. Pramipexole Customers List
Table 154. Pramipexole Market Trends
Table 155. Pramipexole Market Drivers
Table 156. Pramipexole Market Challenges
Table 157. Pramipexole Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Pramipexole Product Picture
Figure 2. Global Pramipexole Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Others Product Picture
Figure 5. Global Pramipexole Market Share by Sales Channel in 2020 & 2027
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Sales
Figure 9. Others
Figure 10. Pramipexole Report Years Considered
Figure 11. Global Pramipexole Sales 2016-2027 (K Units)
Figure 12. Global Pramipexole Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pramipexole Revenue 2016-2027 (US$ Million)
Figure 14. Global Pramipexole Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Pramipexole Sales Market Share by Region (2016-2021)
Figure 16. Global Pramipexole Sales Market Share by Region (2022-2027)
Figure 17. North America Pramipexole Sales YoY (2016-2027) & (K Units)
Figure 18. North America Pramipexole Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Pramipexole Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Pramipexole Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Pramipexole Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Pramipexole Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Pramipexole Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Pramipexole Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Pramipexole Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Pramipexole Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Pramipexole Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Pramipexole Revenue in 2020
Figure 29. Pramipexole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Pramipexole Sales Market Share by Type (2016-2027)
Figure 31. Global Pramipexole Revenue Market Share by Type (2016-2027)
Figure 32. Global Pramipexole Sales Market Share by Sales Channel (2016-2027)
Figure 33. Global Pramipexole Revenue Market Share by Sales Channel (2016-2027)
Figure 34. North America Pramipexole Sales Market Share by Type (2016-2027)
Figure 35. North America Pramipexole Revenue Market Share by Type (2016-2027)
Figure 36. North America Pramipexole Sales Market Share by Sales Channel (2016-2027)
Figure 37. North America Pramipexole Revenue Market Share by Sales Channel (2016-2027)
Figure 38. North America Pramipexole Sales Share by Country (2016-2027)
Figure 39. North America Pramipexole Revenue Share by Country (2016-2027)
Figure 40. United States Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Pramipexole Sales Market Share by Type (2016-2027)
Figure 43. Europe Pramipexole Revenue Market Share by Type (2016-2027)
Figure 44. Europe Pramipexole Sales Market Share by Sales Channel (2016-2027)
Figure 45. Europe Pramipexole Revenue Market Share by Sales Channel (2016-2027)
Figure 46. Europe Pramipexole Sales Share by Country (2016-2027)
Figure 47. Europe Pramipexole Revenue Share by Country (2016-2027)
Figure 48. Germany Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 49. France Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Pramipexole Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Pramipexole Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Pramipexole Sales Market Share by Sales Channel (2016-2027)
Figure 56. Asia Pacific Pramipexole Revenue Market Share by Sales Channel (2016-2027)
Figure 57. Asia Pacific Pramipexole Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Pramipexole Revenue Share by Region (2016-2027)
Figure 59. China Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 62. India Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 64. China Taiwan Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Pramipexole Sales Market Share by Type (2016-2027)
Figure 69. Latin America Pramipexole Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Pramipexole Sales Market Share by Sales Channel (2016-2027)
Figure 71. Latin America Pramipexole Revenue Market Share by Sales Channel (2016-2027)
Figure 72. Latin America Pramipexole Sales Share by Country (2016-2027)
Figure 73. Latin America Pramipexole Revenue Share by Country (2016-2027)
Figure 74. Mexico Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 77. Colombia Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Pramipexole Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Pramipexole Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Pramipexole Sales Market Share by Sales Channel (2016-2027)
Figure 81. Middle East and Africa Pramipexole Revenue Market Share by Sales Channel (2016-2027)
Figure 82. Middle East and Africa Pramipexole Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Pramipexole Revenue Share by Country (2016-2027)
Figure 84. Turkey Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 86. UAE Pramipexole Revenue (2016-2027) & (US$ Million)
Figure 87. Pramipexole Value Chain
Figure 88. Pramipexole Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
世界のプラミペキソール市場インサイト・予測（～2027年） Pramipexole is a dopamine agonist that works on the nervous system to help treat the symptoms of Parkinson disease. Pramipexole is also used to treat Restless Legs Syndrome (RLS). RLS is a neurologic disorder that affects sensation and movement in the legs and causes the legs to feel uncomfortable. …- 薬局自動化システムの世界及び中国市場 Pharmacy Automation is the mechanization or automation of tasks and processes performed in pharmacy or other health care settings. It includes process like medication dispensing, packaging, labeling, storage and retrieval systems and table top counters. The pharmacy automation not only streamline ph…
- 薬局自動化用装置の世界及び中国市場 Pharmacy automation refers to the mechanization and informationization of all drugs from management to final delivery to patients after they enter the hospital. From the perspective of product type and technology, the main types of products in the global pharmacy automation equipment market are auto…
- 病院及び薬局用ロボットの世界市場 2020年 Market Overview The global Hospital and Pharmacy Robotics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospital and P…
- 世界のソラフェニブトシル酸塩錠市場インサイト・予測（～2027年） Sorafenib tosylate Tablets are used as clinical anticancer agents for the treatment of liver and renal cell carcinoma. Market Analysis and Insights: Global Sorafenib Tosylate Tablets Market The global Sorafenib Tosylate Tablets market is valued at US$ XX million in 2020. The market size will reach U…